NEUPHORIA THERAPEUTICS INC
NEUP · NASDAQ
Updated at 2026-10-14 09:27:48
- Today's High
- $3.49
- Today’s Low
- $3.32
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.32
- Previous Close
- $3.32
- Volume
- 10.03K
- Market Cap
- $17.96M
- P/E Ratio
- --
- EPS
- $-5.00
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 14 MILLISTON ROAD, MILLIS, MA, UNITED STATES, 02054
- Country
- US
- Listing Date
- 1999-12-21
- Fiscal Year End
- June
- Shares Outstanding
- 5.4M
- CIK
- 0001191070
- Website
- www.neuphoriatx.com
Neuphoria Therapeutics Inc (Ticker: NEUP) is a groundbreaking biotechnology firm focused on revolutionizing mental health disorders treatment via psychedelic compounds and advanced drug delivery systems. The company boasts a promising pipeline of preclinical candidates, strategically targeting significant unmet needs within the mental healthcare sector, coinciding with the increasing acceptance of alternative therapies. As a frontrunner in the rapidly evolving psychedelic therapy market, Neuphoria offers a compelling investment proposition for institutional investors keen on supporting innovative solutions that may fundamentally alter the landscape of mental health treatment.
Financial Metrics
Revenue
2026-06-30
$1.17M
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$1.17M
2026-03-31
$1M
2025-12-31
$4.06M
2025-09-30
$5.65M
Net Income
2026-06-30
-$4.9M
2026-03-31
-$505.06K
2025-12-31
$1.86M
2025-09-30
-$14.98M
Net Profit Margin
2026-06-30
-417.69%
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.13
2026-03-31
$-0.09
2025-12-31
$0.41
2025-09-30
$-4.41
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$1.76K
2026-03-31
-$1M
2025-12-31
-$3.34M
2025-09-30
-$8.38M
Effective Tax Rate
2026-06-30
0.7%
2026-03-31
6.44%
2025-12-31
-1.9%
2025-09-30
0.34%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $1.17M | $0 | $0 | $0 |
| Operating Expenses | $1.17M | $1M | $4.06M | $5.65M |
| Net Income | -$4.9M | -$505.06K | $1.86M | -$14.98M |
| Net Profit Margin | -417.69% | -- | -- | -- |
| Earnings Per Share | $-0.13 | $-0.09 | $0.41 | $-4.41 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $1.76K | -$1M | -$3.34M | -$8.38M |
| Effective Tax Rate | 0.7% | 6.44% | -1.9% | 0.34% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.